{
    "clinical_study": {
        "@rank": "26852", 
        "arm_group": [
            {
                "arm_group_label": "Krill oil low dose", 
                "arm_group_type": "Experimental", 
                "description": "3 capsules krill oil per day, for 28 days"
            }, 
            {
                "arm_group_label": "Krill oil high dose", 
                "arm_group_type": "Experimental", 
                "description": "9 capsules krill oil per day, for 28 days"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to examine whether 4 weeks daily intake of krill oil can change\n      the omega-3 index (content of the long chained fatty acids EPA and DHA in relation to the\n      total fatty acids) in the membrane in red blood cells. We investigate this at two different\n      doses. Furthermore, the purpose of the study is also to examine the effect of the krill oil\n      intake on plasma lipids (triacylglycerol, phospholipids and cholesterol), plasma fatty acid\n      composition, as well as product tolerance in healthy, young individuals."
        }, 
        "brief_title": "Krill Oil as Supplementation to Healthy Young Adults.", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Actual"
        }, 
        "condition": "Healthy", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy young adults\n\n        Exclusion Criteria:\n\n          -  Disease/illness\n\n          -  Not able to swallow supplements in capsule form\n\n          -  Not willing to take blood samples"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "36 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "35", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 31, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02053415", 
            "org_study_id": "Krill oil pilot-2014"
        }, 
        "intervention": [
            {
                "arm_group_label": "Krill oil low dose", 
                "description": "3 capsules krill oil per day", 
                "intervention_name": "Krill oil low dose", 
                "intervention_type": "Dietary Supplement", 
                "other_name": "Rimfrost Sublime krill oil"
            }, 
            {
                "arm_group_label": "Krill oil high dose", 
                "description": "9 capsules krill oil per day", 
                "intervention_name": "Krill oil high dose", 
                "intervention_type": "Dietary Supplement", 
                "other_name": "Rimfrost Sublime krill oil"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "krill oil", 
            "omega-3 index", 
            "plasma lipid profile", 
            "tolerance", 
            "young adults"
        ], 
        "lastchanged_date": "March 13, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Bergen", 
                    "country": "Norway", 
                    "zip": "5020"
                }, 
                "name": "Department of Clinical Science, University of Bergen"
            }
        }, 
        "location_countries": {
            "country": "Norway"
        }, 
        "number_of_arms": "2", 
        "official_title": "Study of the Effect of Krill Oil Supplement on Omega-3 Fatty Acid Index and Tolerance", 
        "overall_official": {
            "affiliation": "University of Bergen", 
            "last_name": "Per Bakke, Professor", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Norway:National Committee for Medical and Health Research Ethics", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Change in fatty acid composition and omega-3 index (sum of % EPA and DHA)", 
            "measure": "Fatty acid composition in red blood cells (the membrane)", 
            "safety_issue": "No", 
            "time_frame": "Day 0 (baseline), and day 28 (end)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02053415"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Bergen", 
            "investigator_full_name": "Bodil Bj\u00f8rndal", 
            "investigator_title": "Researcher", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Change in triacylglycerol levels.\nChange in phospholipid levels.\nChange in cholesterol levels (total, ester, free, HDL, LDL).", 
                "measure": "Fasting plasma lipid status", 
                "safety_issue": "No", 
                "time_frame": "Day o (baseline), and day 28 (end)"
            }, 
            {
                "description": "Change in fatty acid composition and omega-3 index (sum of % EPA and DHA).", 
                "measure": "Fatty acid composition in plasma.", 
                "safety_issue": "No", 
                "time_frame": "Day 0 (baseline), and day 28 (end)"
            }, 
            {
                "description": "Change in fasting glucose and glucose tolerance.", 
                "measure": "Fasting glucose and glucose tolerance.", 
                "safety_issue": "No", 
                "time_frame": "Day 0 (baseline), and day 28 (end)"
            }, 
            {
                "description": "Questionnaire-based", 
                "measure": "Tolerance of and compliance with intervention", 
                "safety_issue": "No", 
                "time_frame": "Day 28 (end)"
            }
        ], 
        "source": "University of Bergen", 
        "sponsors": {
            "collaborator": {
                "agency": "Olympic Seafood AS", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "University of Bergen", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}